BDBM50026691 4-Benzyloxycarbonylamino-4-{1-[1-({[1-[1-(1-carbamoyl-2-carboxy-ethylcarbamoyl)-3-methylsulfanyl-propylcarbamoyl]-2-(1H-indol-3-yl)-ethylcarbamoyl]-methyl}-carbamoyl)-2-(4-hydroxy-phenyl)-ethylcarbamoyl]-ethylcarbamoyl}-butyric acid::CHEMBL407736

SMILES CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(O)=O)C(N)=O

InChI Key InChIKey=SYDYUBVZGGKNTG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50026691   

TargetCholecystokinin receptor type A(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50026691(4-Benzyloxycarbonylamino-4-{1-[1-({[1-[1-(1-carbam...)
Affinity DataIC50: 5.00E+3nMAssay Description:Compound was tested for in vitro inhibition of the binding of [125I](Nle11)-HG-13 to Histamine H2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed